DK1753776T3 - Camptotheciner, som er konjugeret i 7-stillingen til cykliske peptider, som cytostatiske midler - Google Patents

Camptotheciner, som er konjugeret i 7-stillingen til cykliske peptider, som cytostatiske midler

Info

Publication number
DK1753776T3
DK1753776T3 DK05742726T DK05742726T DK1753776T3 DK 1753776 T3 DK1753776 T3 DK 1753776T3 DK 05742726 T DK05742726 T DK 05742726T DK 05742726 T DK05742726 T DK 05742726T DK 1753776 T3 DK1753776 T3 DK 1753776T3
Authority
DK
Denmark
Prior art keywords
camptothecins
conjugated
cyclic peptides
cytostatic agents
cytostatic
Prior art date
Application number
DK05742726T
Other languages
Danish (da)
English (en)
Inventor
Pozzo Alma Dal
Sergio Penco
Lucio Merlini
Giuseppe Giannini
Maria Ornella Tinti
Claudio Pisano
Franco Zunino
Domenico Alloatti
Loredana Vesci
Sabrina Dallavalle
Ming Hong Ni
Original Assignee
Sigma Tau Ind Farmaceuti
Ist Naz Stud Cura Dei Tumori
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sigma Tau Ind Farmaceuti, Ist Naz Stud Cura Dei Tumori filed Critical Sigma Tau Ind Farmaceuti
Application granted granted Critical
Publication of DK1753776T3 publication Critical patent/DK1753776T3/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/64—Cyclic peptides containing only normal peptide links
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/50—Cyclic peptides containing at least one abnormal peptide link
    • C07K7/52—Cyclic peptides containing at least one abnormal peptide link with only normal peptide links in the ring
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/12—Cyclic peptides, e.g. bacitracins; Polymyxins; Gramicidins S, C; Tyrocidins A, B or C
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A61P35/04—Antineoplastic agents specific for metastasis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oncology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Communicable Diseases (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Virology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Immunology (AREA)
  • Epidemiology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
DK05742726T 2004-05-13 2005-05-04 Camptotheciner, som er konjugeret i 7-stillingen til cykliske peptider, som cytostatiske midler DK1753776T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
IT000240A ITRM20040240A1 (it) 2004-05-13 2004-05-13 Camptotecine coniugate in posizione 7 con antagonisti delle integrine.
PCT/IT2005/000260 WO2005111063A1 (fr) 2004-05-13 2005-05-04 Camptothecines conjuguees en position 7 avec des peptides cycliques utilisees comme agents cytostatiques

Publications (1)

Publication Number Publication Date
DK1753776T3 true DK1753776T3 (da) 2009-05-11

Family

ID=34968014

Family Applications (1)

Application Number Title Priority Date Filing Date
DK05742726T DK1753776T3 (da) 2004-05-13 2005-05-04 Camptotheciner, som er konjugeret i 7-stillingen til cykliske peptider, som cytostatiske midler

Country Status (23)

Country Link
US (1) US7705012B2 (fr)
EP (1) EP1753776B1 (fr)
JP (1) JP4805917B2 (fr)
KR (1) KR101145815B1 (fr)
CN (1) CN1953989B (fr)
AR (1) AR048949A1 (fr)
AT (1) ATE420891T1 (fr)
AU (1) AU2005243417B2 (fr)
BR (1) BRPI0510983A (fr)
CA (1) CA2563708A1 (fr)
CY (1) CY1108985T1 (fr)
DE (1) DE602005012390D1 (fr)
DK (1) DK1753776T3 (fr)
ES (1) ES2321114T3 (fr)
HR (1) HRP20090146T3 (fr)
IT (1) ITRM20040240A1 (fr)
MX (1) MXPA06012884A (fr)
PL (1) PL1753776T3 (fr)
PT (1) PT1753776E (fr)
RS (1) RS51169B (fr)
SI (1) SI1753776T1 (fr)
TW (1) TWI352703B (fr)
WO (1) WO2005111063A1 (fr)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ITRM20040239A1 (it) * 2004-05-13 2004-08-13 Sigma Tau Ind Farmaceuti Derivati ciclopeptidici ad attivita' antintegrine.
WO2008098701A1 (fr) * 2007-02-13 2008-08-21 Sigma-Tau Industrie Farmaceutiche Riunite S.P.A. Traitement anti-cancéreux à large spectre à base de dérivés d'iminocamptothécine
TW201004647A (en) * 2008-05-20 2010-02-01 Sigma Tau Ind Farmaceuti Novel dual targeting antitumoural conjugates
WO2011002852A2 (fr) * 2009-06-30 2011-01-06 The Regents Of The University Of Michigan Complexes de pro-médicaments et leurs procédés d’utilisation
WO2011079015A1 (fr) * 2009-12-21 2011-06-30 The Regents Of The University Of California Peptides cycliques contenant rgd
US8685928B2 (en) 2010-02-12 2014-04-01 Dana-Farber Cancer Institute, Inc. Antagonists of MUC1
WO2013026015A1 (fr) 2011-08-18 2013-02-21 Dana-Farber Cancer Institute, Inc. Pièges de ligand de muc1 pour l'utilisation dans le traitement de cancers
CN102516258B (zh) * 2011-11-11 2014-06-25 正大天晴药业集团股份有限公司 水溶性维生素e衍生物修饰的脂溶性抗癌药物化合物和制剂、该化合物的制备方法及应用
US9044421B2 (en) 2012-03-28 2015-06-02 Genus Oncology, Llc Treating MUC1-expressing cancers with combination therapies
US10420845B2 (en) 2015-06-18 2019-09-24 Ramot At Tel-Aviv University Ltd. Taggable heteroaromatic drugs and conjugates thereof
US10494403B2 (en) * 2018-03-06 2019-12-03 Ciphore Biomed Technology Limited Company Cyclopeptide, pharmaceutical or cosmetic composition comprising the same and method for preparing the same
CN115590975A (zh) * 2022-11-15 2023-01-13 无锡福祈制药有限公司（Cn） 丝裂霉素-rgd肽偶联物及其制备方法

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0540099B1 (fr) * 1991-10-29 1996-04-17 Glaxo Wellcome Inc. Dérivés de camptothécine solubles dans l'eau
US5646159A (en) * 1994-07-20 1997-07-08 Research Triangle Institute Water-soluble esters of camptothecin compounds
CA2192725C (fr) 1995-12-28 2004-04-20 Kenji Tsujihara Derives de la camptothecine
ATE329903T1 (de) * 1997-02-14 2006-07-15 Bionumerik Pharmaceuticals Inc Hochgradig lipophile camptothecin-derivate
DE19815812A1 (de) * 1998-04-08 1999-10-14 Bayer Ag Modifizierte Cytostatika
ATE216998T1 (de) 1999-03-09 2002-05-15 Sigma Tau Ind Farmaceuti Camptothecin-derivate mit antitumor-wirkung
PL354268A1 (en) * 1999-09-08 2003-12-29 BAYER AktiengesellschaftBAYER Aktiengesellschaft Integrin-mediated drug targeting
IL155139A0 (en) * 2000-10-06 2003-10-31 Novartis Ag Targeting molecules for adenoviral vectors
JP2004535407A (ja) * 2001-05-30 2004-11-25 ターゲサム・インコーポレーテッド 標的化多価高分子

Also Published As

Publication number Publication date
TWI352703B (en) 2011-11-21
KR20070012530A (ko) 2007-01-25
US7705012B2 (en) 2010-04-27
EP1753776B1 (fr) 2009-01-14
KR101145815B1 (ko) 2012-05-16
HRP20090146T3 (en) 2009-05-31
BRPI0510983A (pt) 2007-12-04
CN1953989A (zh) 2007-04-25
CY1108985T1 (el) 2014-07-02
JP4805917B2 (ja) 2011-11-02
AU2005243417A2 (en) 2005-11-24
AR048949A1 (es) 2006-06-14
ATE420891T1 (de) 2009-01-15
RS51169B (sr) 2010-10-31
WO2005111063A1 (fr) 2005-11-24
DE602005012390D1 (de) 2009-03-05
CN1953989B (zh) 2012-10-10
JP2008504235A (ja) 2008-02-14
AU2005243417B2 (en) 2011-07-07
US20080033003A1 (en) 2008-02-07
MXPA06012884A (es) 2007-02-15
PL1753776T3 (pl) 2009-06-30
TW200606165A (en) 2006-02-16
ITRM20040240A1 (it) 2004-08-13
PT1753776E (pt) 2009-03-05
SI1753776T1 (sl) 2009-06-30
AU2005243417A1 (en) 2005-11-24
CA2563708A1 (fr) 2005-11-24
EP1753776A1 (fr) 2007-02-21
ES2321114T3 (es) 2009-06-02

Similar Documents

Publication Publication Date Title
DK1753776T3 (da) Camptotheciner, som er konjugeret i 7-stillingen til cykliske peptider, som cytostatiske midler
ATE556078T1 (de) 2,4,6-phenylsubstituierte cyclische ketoenole
DE602005022897D1 (de) Piperidinylamino-thienoä2,3-dü-pyrimidinverbindungen
DK1902037T3 (da) 2,4-diamino-pyrimidiner som auroainhibitorer
DOP2007000080A (es) Piridin [3,4-b] pirazinonas
DE602005007488D1 (de) Zusammensetzung mit interkalierten funktionell aktiven organischen verbindungen
NO20091395L (no) Nye tiofenderivater
DK1856042T3 (da) Substituerede gamma-lactamer som terapeutiske midler
DK1661627T3 (da) Dyseanordning
DK3348624T3 (da) Sammensætninger, der omfatter hfc-1234yf
BRPI0508788A (pt) tiadiazolidinonas como inibidores de sqg - 3
MX2010005889A (es) Derivados de tiofeno como agonistas de s1p1/edg1.
ATE412651T1 (de) Pyrrolopyridinderivate
DE602005017746D1 (de) Zusammensetzungen mit fluorsubstituierten olefinen
DE502005007723D1 (de) 18-methyl-19-nor-17-pregn-4-en-21,17-carbolactone,
DE502005000502D1 (de) Vernetzbare Polyorganosiloxanmassen
ATE537171T1 (de) Aryl-isoxazol-4-yl-imidazoä1,5-aüpyridin-deriva e
NL2000336A1 (nl) Spirocyclische derivaten.
DE602005007364D1 (de) Peptidcyclisierung
DE602005013516D1 (de) Nockenrolle
DE112005000889A5 (de) Turboladerstütze
DE602006015573D1 (de) Bipolarplatte
DK1963295T3 (da) 3,6-dihydro-2-oxo-6H-(1,3,4)thiazinderivater
DE602005010986D1 (de) Neue pyrrolidin-3,4-dicarbonsäureamidderivate
ATE445604T1 (de) Neue 2,6-diaminopyridin-3-on-derivate